BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
May 17, 2013
BioLineRx Reports First Quarter 2013 Results
May 07, 2013
(JNJ) BioLineRx to Start BL-8040 Study
April 27, 2013
BioLineRx (BLRX) recently received approval in the US for the initiation of a multi-center,... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
BioLineRx (BLRX) Hits Primary Endpoint in BL-7040 Phase IIa
April 17, 2013
Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
April 16, 2013
from PR Newswire
category
companyNews
category
companyNews
Morning Market Movers
April 10, 2013
category
companyNews
BioLineRx (BLRX) Approved to Commence BL-8040 Phase IIa
April 10, 2013
Upcoming Trial Data May Help Salvage Bioline Rx
April 03, 2013
After providing the public with less-than-stellar results last month from their high-profile Phase II/III CLARITY trial, the pharmaceutical company Bioline RX (NASDAQ: BLRX) dropped to a new 52-week... Read More
category
BLRX
,
Brian L/ Wilson
from Bio-Wire.Com
from PR Newswire
category
companyNews
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here